 |
PDBsum entry 5flc
|
|
|
|
 |
Contents |
 |
|
|
|
|
|
|
|
|
|
615 a.a.
|
 |
|
|
|
|
|
|
|
365 a.a.
|
 |
|
|
|
|
|
|
|
1029 a.a.
|
 |
|
|
|
|
|
|
|
1050 a.a.
|
 |
|
|
|
|
|
|
|
107 a.a.
|
 |
|
|
|
|
|
|
|
317 a.a.
|
 |
|
|
|
|
|
|
|
|
|
PDB id:
|
 |
|
 |
| Name: |
 |
Transferase
|
 |
|
Title:
|
 |
Architecture of human mtor complex 1 - 5.9 angstrom reconstruction
|
|
Structure:
|
 |
Serine/threonine-protein kinase mtor. Chain: 1, 3. Fragment: horn domain. Synonym: fk506-binding protein 12-rapamycin complex-associated protein 1, fkbp12-rapamycin complex-associated protein, mammalian target of rapamycin, mtor, mechanistic target of rapamycin, rapamycin and fkbp12 target 1, rapamycin target protein 1. Engineered: yes. Serine/threonine-protein kinase mtor.
|
|
Source:
|
 |
Homo sapiens. Human. Organism_taxid: 9606. Expressed in: spodoptera frugiperda. Expression_system_taxid: 7108. Expression_system_cell_line: sf21. Spodoptera frugiperda. Fall armyworm. Organism_taxid: 7108.
|
|
Authors:
|
 |
C.H.S.Aylett,E.Sauer,S.Imseng,D.Boehringer,M.N.Hall,N.Ban,T.Maier
|
|
Key ref:
|
 |
C.H.Aylett
et al.
(2016).
Architecture of human mTOR complex 1.
Science,
351,
48-52.
PubMed id:
DOI:
|
 |
|
Date:
|
 |
|
23-Oct-15
|
Release date:
|
30-Dec-15
|
|
|
|
|
|
PROCHECK
|
|
|
|
|
Headers
|
 |
|
|
References
|
|
|
|
|
|
|
No UniProt id for this chain
|
|
|
|
|
|
|
|
|
 |
 |
|
|
|
|
No UniProt id for this chain
|
|
|
|
|
|
|
|
|
 |
 |
|
|
|
|
No UniProt id for this chain
|
|
|
|
|
|
|
|
|
 |
 |
|
|
|
|
P42345
(MTOR_HUMAN) -
Serine/threonine-protein kinase mTOR from Homo sapiens
|
|
|
|
Seq: Struc:
|
 |
 |
 |
2549 a.a.
1050 a.a.
|
|
|
|
|
|
|
|
|
 |
 |
|
 |
|
|
 |
 |
 |
 |
Enzyme class 1:
|
 |
Chains B, F:
E.C.2.7.11.1
- non-specific serine/threonine protein kinase.
|
|
 |
 |
 |
 |
 |
Reaction:
|
 |
|
1.
|
L-seryl-[protein] + ATP = O-phospho-L-seryl-[protein] + ADP + H+
|
|
2.
|
L-threonyl-[protein] + ATP = O-phospho-L-threonyl-[protein] + ADP + H+
|
|
 |
 |
 |
 |
 |
L-seryl-[protein]
|
+
|
ATP
|
=
|
O-phospho-L-seryl-[protein]
|
+
|
ADP
|
+
|
H(+)
|
|
 |
 |
 |
 |
 |
L-threonyl-[protein]
|
+
|
ATP
|
=
|
O-phospho-L-threonyl-[protein]
|
+
|
ADP
|
+
|
H(+)
|
|
 |
 |
 |
 |
 |
 |
 |
 |
Enzyme class 2:
|
 |
Chains D, H:
E.C.?
|
|
 |
 |
 |
 |
 |
 |
 |
|
Note, where more than one E.C. class is given (as above), each may
correspond to a different protein domain or, in the case of polyprotein
precursors, to a different mature protein.
|
|
 |
|
Molecule diagrams generated from .mol files obtained from the
KEGG ftp site
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
| |
|
|
| |
|
DOI no:
|
Science
351:48-52
(2016)
|
|
PubMed id:
|
|
|
|
|
| |
|
Architecture of human mTOR complex 1.
|
|
C.H.Aylett,
E.Sauer,
S.Imseng,
D.Boehringer,
M.N.Hall,
N.Ban,
T.Maier.
|
|
|
|
| |
ABSTRACT
|
|
|
| |
|
Target of rapamycin (TOR), a conserved protein kinase and central controller of
cell growth, functions in two structurally and functionally distinct complexes:
TORC1 and TORC2. Dysregulation of mammalian TOR (mTOR) signaling is implicated
in pathologies that include diabetes, cancer, and neurodegeneration. We resolved
the architecture of human mTORC1 (mTOR with subunits Raptor and mLST8) bound to
FK506 binding protein (FKBP)-rapamycin, by combining cryo-electron microscopy at
5.9 angstrom resolution with crystallographic studies of Chaetomium thermophilum
Raptor at 4.3 angstrom resolution. The structure explains how FKBP-rapamycin and
architectural elements of mTORC1 limit access to the recessed active site.
Consistent with a role in substrate recognition and delivery, the conserved
amino-terminal domain of Raptor is juxtaposed to the kinase active site.
|
|
|
|
|
|
|
 |
 |
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
');
}
}
| | |